4Indexed trials
drug · Product Intelligence
Lecanemab
Pipeline Intelligence
Lecanemab: 4 indexed trials, 3 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
3Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT04468659Eisai Inc. · alzheimersPHASE3
NCT05269394Washington University School of Medicine · alzheimersPHASE2, PHASE3
NCT06285448HealthPartners Institute · alzheimersENROLLING_BY_INVITATION
NCT06602258Eisai Inc. · alzheimersPHASE2
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.